Filtra per Last updated date SelectDopoPrimaFrom - To Date Data di conclusione Questa settimana Questo mese Ultima settimana Ultimo mese Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorPRIMEParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Esito (3827) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 23-26 January 2023 27 Gennaio 2023NewsHumanMedicines EMA Committee for Advanced Therapies elects Ilona Reischl as its new Chair 26 Gennaio 2023NewsCorporate Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 17-18 January 2023 20 Gennaio 2023NewsVeterinaryMedicines Joint statement by Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) on shortages of antibiotic medicines 20 Gennaio 2023NewsHumanMedicines Assessment of human dietary exposure to residues of veterinary medicines in the EU 19 Gennaio 2023NewsHumanVeterinaryMedicines Mandatory use of CTIS from 31 January 2023 for all new clinical trial applications 19 Gennaio 2023NewsHumanClinical trials Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 9 - 12 January 2023 13 Gennaio 2023NewsHumanPharmacovigilanceReferrals EMA confirms measures to minimise risk of serious side effects with Janus kinase inhibitors for chronic inflammatory disorders 13 Gennaio 2023NewsHumanReferrals End-of-year message from EMA’s Executive Director 21 Dicembre 2022NewsCorporate EMA business hours over holiday period 20 Dicembre 2022NewsCorporateCOVID-19 1 … 34 35 36 37 38 Page 38 of 383 39 40 41 42 … 383
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 23-26 January 2023 27 Gennaio 2023NewsHumanMedicines
EMA Committee for Advanced Therapies elects Ilona Reischl as its new Chair 26 Gennaio 2023NewsCorporate
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 17-18 January 2023 20 Gennaio 2023NewsVeterinaryMedicines
Joint statement by Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) on shortages of antibiotic medicines 20 Gennaio 2023NewsHumanMedicines
Assessment of human dietary exposure to residues of veterinary medicines in the EU 19 Gennaio 2023NewsHumanVeterinaryMedicines
Mandatory use of CTIS from 31 January 2023 for all new clinical trial applications 19 Gennaio 2023NewsHumanClinical trials
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 9 - 12 January 2023 13 Gennaio 2023NewsHumanPharmacovigilanceReferrals
EMA confirms measures to minimise risk of serious side effects with Janus kinase inhibitors for chronic inflammatory disorders 13 Gennaio 2023NewsHumanReferrals